Effects of skin care protocol on the severity of Incontinence Associated Dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200717001

Enrollment

Registered

2020-07-17

Start date

2020-03-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incontinence Associated Dermatitis ncontinence Associated Dermatitis skin care protocol.

Interventions

Subjects were assigned to the control group receiving Standard skin care include cleansing with a soap and water&#44

drying using a soft towel rubbing technique. Apply zinc paste 2 times a day&#44

morning and evening. And under pads was used. Frequent 2&#45

4 hour&#44

change of linen and repositioning patient. ,The skin care protocol was developed based on literature review. It includes inspection&#44

gentle cleansing (chula soap) use for daily perineal skin hygiene 2 times a day&#44

morning and evening. Drying by evaporation was recommended and no towel rubbing or patting was allowed after applying zinc oxide powder and no sting barrier film. If the perineal area was extremely so

change of linen and repositioning patient. Implement skin care protocol for one week.

Experimental Procedure/Surgery,Experimental Procedure/Surgery

Standard skin care,Skin care protocol on the severity of Incontinence Associated Dermatitis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients were affected by IAD (mild-severe IAD), newly admitted or after admission and age 18 years or older

Exclusion criteria

Exclusion criteria: Patients were excluded from the study if they have any of these conditions: open sore on perineal skin caused by pressure / shear, diagnosed skin disease of the perineum and known allergy influencing skin integrity.Known allergy or hypersensitivity to cleanser or zinc oxide barrier spray, other significant skin disease or dermatological problem, indwelling urinary catheterization

Design outcomes

Primary

Measure	Time frame
Severity of incontinence associated dermatitis at 7 days after end of the intervention Number of participants with incontinence associated dermatitis (IAD) (residual, i.e. not healed)	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactNisachon Kwangthong

Mahidol University

nisahchon@gmail.com084-6643744

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026